Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin

Katharina Medek; Sylvia Selhofer; Buchner Matthias; Ulrich Mrowietz; Martin Laimer

doi:10.1111/pde.14994

Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin

Katharina Medek^* (Erstautor/-in), Sylvia Selhofer (Co-Autor/-in), Buchner Matthias, Ulrich Mrowietz, Martin Laimer (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

8 Quellenangaben (Web of Science)

Abstract

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.

Originalsprache	Englisch
Seiten (von - bis)	659-661
Fachzeitschrift	PEDIATRIC DERMATOLOGY
Jahrgang	39
Ausgabenummer	4
DOIs	https://doi.org/10.1111/pde.14994
Publikationsstatus	Veröffentlicht - 20 Juli 2022

Zugriff auf Dokument

10.1111/pde.14994Lizenz: Nicht angegeben

8 Zitationen
1 Korrektur

Corrigendum to “Successful treatment of a child's pityriasis rubra pilaris (PRP)with ustekinumab and acitretin”
Medek, K., Selhofer, S., Buchner, M., Mrowietz, U. & Laimer, M., Sept. 2023, in: PEDIATRIC DERMATOLOGY . 40, 5, 1 S., 971.
Publikation: Beitrag in Fachzeitschrift › Korrektur › Begutachtung

Dieses zitieren

Medek, K., Selhofer, S., Matthias, B., Mrowietz, U., & Laimer, M. (2022). Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin. PEDIATRIC DERMATOLOGY , 39(4), 659-661. https://doi.org/10.1111/pde.14994

Medek, Katharina ; Selhofer, Sylvia ; Matthias, Buchner et al. / Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin. in: PEDIATRIC DERMATOLOGY 2022 ; Jahrgang 39, Nr. 4. S. 659-661.

@article{5b6f68e803cf45fc90583cb8dd289879,

title = "Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin",

abstract = "Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.",

author = "Katharina Medek and Sylvia Selhofer and Buchner Matthias and Ulrich Mrowietz and Martin Laimer",

note = "Medek, Selhofer, Laimer: Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Buchner: Department of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2022",

month = jul,

day = "20",

doi = "10.1111/pde.14994",

language = "English",

volume = "39",

pages = "659--661",

journal = "PEDIATRIC DERMATOLOGY ",

issn = "0736-8046",

publisher = "Wiley Verlag ",

number = "4",

}

Medek, K, Selhofer, S, Matthias, B, Mrowietz, U & Laimer, M 2022, 'Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin', PEDIATRIC DERMATOLOGY , Jg. 39, Nr. 4, S. 659-661. https://doi.org/10.1111/pde.14994

Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin. / Medek, Katharina (Erstautor/-in); Selhofer, Sylvia (Co-Autor/-in); Matthias, Buchner et al.
in: PEDIATRIC DERMATOLOGY , Jahrgang 39, Nr. 4, 20.07.2022, S. 659-661.

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

TY - JOUR

T1 - Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin

AU - Medek, Katharina

AU - Selhofer, Sylvia

AU - Matthias, Buchner

AU - Mrowietz, Ulrich

AU - Laimer, Martin

N1 - Medek, Selhofer, Laimer: Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Buchner: Department of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2022/7/20

Y1 - 2022/7/20

N2 - Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.

AB - Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.

U2 - 10.1111/pde.14994

DO - 10.1111/pde.14994

M3 - Case report

C2 - 35859269

SN - 0736-8046

VL - 39

SP - 659

EP - 661

JO - PEDIATRIC DERMATOLOGY

JF - PEDIATRIC DERMATOLOGY

IS - 4

ER -

Medek K, Selhofer S, Matthias B, Mrowietz U, Laimer M. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin. PEDIATRIC DERMATOLOGY . 2022 Jul 20;39(4):659-661. doi: 10.1111/pde.14994

Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin

Abstract

Zugriff auf Dokument

Publikationen

Corrigendum to “Successful treatment of a child's pityriasis rubra pilaris (PRP)with ustekinumab and acitretin”

Dieses zitieren